ODDB.org: Open Drug Database

Spirig HealthCare AG - Venlafaxin Spirig HC retard 150 mg, Hartkapseln, retardiert

Swissmedic Registration	67685	Sequence	03
Product name	Venlafaxin Spirig HC retard 150 mg	Description	Hartkapseln, retardiert
ATC-Classification	N06AX16	ATC-Description	Venlafaxine
Introduction of Sequence	14.08.2020

Composition

venlafaxinum 150 mg ut venlafaxini hydrochloridum, cellulosum microcristallinum, povidonum, talcum, silica colloidalis anhydrica, magnesii stearas, Überzug: ethylcellulosum, copovidonum, Kapselhülle: gelatina, E 133, E 129 0.2 mg, E 110 0.4 mg, E 171, aqua purificata, Drucktinte: lacca, propylenglycolum, natrii hydroxidum, povidonum, E 171, pro capsula.

Packungsbestandteile

Galenic Form

Capsules

Active Agent	Dose
Venlafaxine	150 mg

BAG: Active Agent	Dose
Venlafaxine	150 mg

Inactive agents	Dose	additional_information
Aqua Purificata


	0.4 mg	color.
	0.2 mg	color.
		color.
		color.
		Überzug
Gelatina		Kapselhülle
		Drucktinte

Sodium Hydroxide
Povidone

Propylenglycol
Silica Colloidalis Anhydrica
Talcum

Package number	Package Size	EFP	CP	Category	SL	Out of trade (MedRef)
016	14	11.00	28.40	B	SL	Yes
017	28	21.75	40.10	B	SL	Yes
018	98	77.67	100.80	B	SL	Yes

2025	©ywesee GmbH